FRE — Firebrick Pharma Balance Sheet
0.000.00%
- AU$14.71m
- AU$13.80m
- AU$0.01m
Annual balance sheet for Firebrick Pharma, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.093 | 1.15 | 7.14 | 2.35 | 0.825 |
Net Total Receivables | 0.561 | 0.503 | 1.08 | 0.137 | 0.951 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.654 | 1.67 | 8.33 | 2.59 | 2.09 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.001 | 0.016 | 0.042 | 0.034 | 0.027 |
Other Long Term Assets | |||||
Total Assets | 0.655 | 1.76 | 8.73 | 2.98 | 2.41 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.21 | 0.215 | 0.45 | 0.506 | 0.291 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.264 | 0.215 | 0.45 | 0.506 | 0.291 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 0.391 | 1.55 | 8.28 | 2.48 | 2.12 |
Total Liabilities & Shareholders' Equity | 0.655 | 1.76 | 8.73 | 2.98 | 2.41 |
Total Common Shares Outstanding |